Journal Report

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH

Download PDF
Journal Information
Journal Title
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Publisher
TAYLOR & FRANCIS LTD
ISSN
1473-7167
E-ISSN
1744-8379
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Expert review of pharmacoeconomics and outcomes Research: high impact articles from 2025
Tamas Agh, Mickael Hiligsmann, Carolyn Gotay et al.
2026-10-20
DOI: 10.1080/14737167.2026.2752198
Assessing health related quality of life of patients on maintenance hemodialysis in north-western Morocco
Rania Mourchid, Amal Yassine, Yahia Cherrah et al.
2026-10-20
DOI: 10.1080/14737167.2026.2753082
Cost-utility of expanded hypertension screening and treatment among adults covered by Peru’s Seguro Integral de Salud: a Markov model using national data
Víctor Juan Vera-Ponce, Jhosmer Ballena-Caicedo
2026-10-18 Pages 1-10
DOI: 10.1080/14737167.2026.2751401
Machine learning in comparative effective research of pharmacological interventions: a scoping review
Zhen Wang, Bijan J. Borah
2026-10-15 Pages 1-11
DOI: 10.1080/14737167.2026.2746821
Cost-effectiveness of amivantamab plus lazertinib and osimertinib plus chemotherapy versus osimertinib monotherapy for first-line EGFR-mutated advanced non-small cell lung cancer: an updated analysis
Pooja Gokhale, Joshua Caballero, Niying Li et al.
2026-10-15 Pages 1-15
DOI: 10.1080/14737167.2026.2746857
Defining value criteria for outcomes-based managed entry agreements in CAR-T therapy for relapsed/refractory multiple myeloma: a multi-criteria decision analysis study
María Victoria Mateos Manteca, José Luis Poveda Andrés, Albert Oriol Rocafiguera et al.
2026-10-14 Pages 1-10
DOI: 10.1080/14737167.2026.2739076
The presence of prior-effects of the Medicaid expansion on drug prescription
Andrew Kim, Taisuke Sadayuki
2026-10-12 Pages 1-12
DOI: 10.1080/14737167.2026.2746156
Cost-effectiveness of RIMS1 methylation-guided gastric cancer surveillance after <i>Helicobacter pylori</i> eradication
Yifan Qiu, Xianzhu Zhou, Hao Hu et al.
2026-10-11 Pages 1-9
DOI: 10.1080/14737167.2026.2746232
Cost-effectiveness of microaxial flow pump versus standard of care in the management of Cardiogenic shock in Spain
Rut Andrea, Alfonso Jurado-Román, Sandra O. Rosillo et al.
2026-10-11 Pages 1-10
DOI: 10.1080/14737167.2026.2743886
Wholesale, pharmacy mark-up, and retail price dynamics under a declaration-based medicine pricing reform in Kosovo
Toskë Kryeziu, Mimoza Basholli Salihu, Venesa Lupçi et al.
2026-10-9 Pages 1-11
DOI: 10.1080/14737167.2026.2746142
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 27, 2026 15:09